Prostate cancer, one of the most common cancers among men, has come under renewed focus amid rising cases globally and in ...

Joe Biden's recent diagnosis of metastatic prostate cancer has ignited national conversations about age and health in ...

2025 also celebrates 10 years of partnership with luxury helmet makers, Hedon, who created unique helmets to reward 100 of ...

After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product. Anktiva (nogapendekin ...